Stellar Scientific and Exymes team up to deliver innovative, highly efficient DNA extraction solutions to research facilities across the United States. Stellar Scientific – a leading national supplier of research products, tools, and laboratory equipment, has a strategic distribution partnership with Exymes, an innovative developer of molecular biology reagents. This collaboration brings next-generation DNA and […]
ATLANTA, GA, UNITED STATES — Omega Bio-tek, a leading provider of nucleic acid purification solutions, today announced the completion of a significant expansion of its Research and Development facility at its Oakbrook location, increasing the company’s R&D footprint by approximately 50% and reinforcing its ongoing investment in scientific innovation, product development, and collaboration. The expanded facility is designed […]
Financing includes a $17 million senior credit facility from BOK Financial and $8 million in equity from existing investors and global single-family offices. SAN FRANCISCO — Excedr, Inc. (“Excedr” or the “Company”), a leading provider of full-service laboratory equipment leasing solutions for the life sciences and healthcare industries, today announced the closing of $25 million […]
Lucid Genomics provides in-kind access to its genomic analysis platform for laboratories participating in global undiagnosed disease genomics program. By providing our platform in-kind, we hope to help reduce barriers to genomic diagnostics and support Genetic Alliance’s efforts to expand equitable access for patients with rare diseases.” — Uira Souto Melo, Co-Founder and CEO at […]
Countable Certified Service Providers are certified by Countable Labs for demonstrated expertise using Countable PCR technology to support studies of all sizes PALO ALTO, Calif. — Countable Labs, the developer of Countable PCR, a breakthrough single-molecule PCR technology redefining how science measures biology, today announced its Countable Certified Service Provider (CSP) program. The Countable CSP […]
Pythia Biosciences and Lexogen recently announced a strategic partnership to empower researchers with deeper biological insights by combining Lexogen’s expertise in RNA sequencing and library preparation with Pythia’s multi-omics data curation and analytics capabilities. Through this collaboration, Pythia will offer Lexogen’s wet-lab capabilities via direct sales and as a core component of its newly launched expanded data ecosystem […]
Supporting ADLM’s focus on collaborative, cross-disciplinary solutions that address laboratory workforce and operational challenges Highlighting innovations in mass spectrometry, next-generation sequencing, digital pathology and AI diagnostics Showcasing Roche’s portfolio across core, molecular and pathology labs and point-of-care settings at booth no. 2901 INDIANAPOLIS — (SIX: RO, ROP; OTCQX: RHHBY) As clinical laboratories face ongoing staffing […]
Highlights combined company’s strong financial position with over $900 million expected at closing, Treeline’s deep clinical-stage pipeline, planned 2027 data updates for TLN-121 and TLN-372, and expected new program clinical starts Includes headline Phase 1 monotherapy data for TLN-121 in relapsed or refractory lymphomas with overall response rate of 84%, complete response rate of 32% and no […]
Dan Malarek, current CEO of Foundation Medicine Inc., appointed President and CEO of Roche Diagnostics North America, effective August 1, 2026 Malarek succeeds Brad Moore, who will retire at the end of July following nearly a decade of distinguished service at Roche Antonio Vergara appointed Chief Commercial Officer to lead U.S. commercial business units INDIANAPOLIS […]
Adam Brown has been appointed Managing Director, assuming responsibility for the day-to-day leadership of the business As part of the transition, Richard Brown will become Chairman after 26 years as Managing Director, while John Clapham will continue supporting the company in his role as Founder. The changes reflect a planned succession process that combines continuity, […]
Pay Invoice
Latest Blogs
-
Laboratory Tool Companies’ Dividends Show Stability
September 29, 2026 10:14 am
-
Automation Provides a Boost for Sample Prep Instrument Market Growth
August 25, 2026 11:49 am
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
